Talk to Alison
00 1 718 618 48 97
Search inside this page
Top countries
Publication dates
Publishers
All regions
data types
Free Market Research Guides to Download
» Purchase Premium Reports
571-610 of about 700 reports
Yearly, From 2003 To 2016
By Business Monitor International
Source: AESGP, AC Nielsen, BMI
Yearly, From 2004 To 2016
By Business Monitor International
Source: The Association of the European Self-Medication Industry (AESGP), The Brazilian Pharmaceutical Indus
Yearly, From 2004 To 2016
By Business Monitor International
Source: The Association of the European Self-Medication Industry (AESGP), BMI, MIS Consulting Ltd, Magyosz
Yearly, From 2003 To 2016
By Business Monitor International
Source: Association of the European Self-Medication Industry (AESGP), BMI
Yearly, From 2003 To 2016
By Business Monitor International
Source: AFAMELA, BMI
Yearly, From 2003 To 2016
By Business Monitor International
Source: Ministry of Health, local news sources, domestic companies, BMI
Yearly, From 2003 To 2016
By Business Monitor International
Source: Association of European Self-Medication Industry (AESGP), Central Statistics Bureau, BMI
Yearly, From 2004 To 2016
By Business Monitor International
Source: Serbian Medicines and Medical Devices Agency (ALiMS), Ministry of Health, local companies, BMI
Yearly, From 2003 To 2016
By Business Monitor International
Source: BMI
Yearly, From 2004 To 2017
By Business Monitor International
Source: Association of the European Self-Medication Society (AESGP), BMI.
This market research report gives a detailed analysis of the Irish OTC pharmaceutical industry and includes analgesics, cough and cold, skin products, vitamins and minerals and digestives sector . Market ...
This market research report gives a detailed analysis of the Australian OTC pharmaceutical industry and includes cough, cold and nasal alergy, dermatology, analgesics, gastrointestinal, vitamins & minerals, ...
This market research report gives a detailed analysis of the Czech pharmaceutical industry and includes prescription and OTC pharmaceuticals. Market assessement is based on factory prices. The information ...
Interest in herbal/traditional products has grown as the emphasis on health and wellness has been increasing. The economic downturn has, however, made consumers more careful with their spending, and they ...
Synopsis WMI's Amexdrug Corporation contains a company overview, key facts, locations and subsidiaries, news and events as well as a SWOT analysis of the company. Summary This SWOT Analysis company profile ...
The product category was switched to OTC status in May 2009. There is much public focus on the dangers and growing problem of obesity in Denmark. Consumers therefore showed keen interest in this first ...
- SWOT Analysis examines the firm ?s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. Bayer Schering, a business division ...
This study covers the state of the North American marine and algae oil Omega-3 ingredient market, examining drivers and restraints for growth, pricing, distribution, technology, legislation, demand and ...
Despite the government's 2003 implementation of the Tobacco Regulation Act (RA 9211), which bans smoking in public areas, NRT smoking cessation aids remained a niche segment in the Philippines in 2009. ...
OTC obesity current value sales declined by 10% in 2009 to reach Ps343 million. Volume sales also declined by 10%. During the first half of the review period, demand for OTC obesity products grew strongly ...
Slimming products experienced a significant slowdown in current value sales growth in 2009 as Filipino consumers started to feel the effects of the global financial crisis. Middle-income consumers - the ...
Having enjoyed healthy growth rates during earlier years of the review period, slimming products were among the victims of the economic crisis. Despite being increasingly exposed to social pressure to ...
Value sales of OTC obesity in Portugal, comprised exclusively of the Alli brand, represented Euros 2 million in 2009. In fact, Alli the active ingredient of which is Oristat, was switched to be available ...
OTC obesity observed 1% current value growth to attain S$1 million sales in 2009. There were reports citing possible liver damage when consuming the OTC obesity drug Ecumenical during 2009 whereby consumers ...
Slimming salons continued to have intensive industry ing campaigns to attract consumers. Television variety programmes shown during prime viewing times were sponsored by key slimming salons such as Citispa. ...
With obesity becoming a major concern among affluent urban consumers, and slimming products? sales gaining momentum, more players have sought a share in a industry dominated by direct sellers. Upscale ...
This market research report gives a detailed analysis of the Dutch OTC pharmaceutical industry and includes dietary supplements, analgesics, cough, cold & throat remedies, skin and hair care, digestive ...
This market research report gives a detailed analysis of the Belgian OTC pharmaceutical industry and includes cough & cold, analgesics, digestives, skin products, vitamins & minerals and others. Market ...
This market research report gives a detailed analysis of the Swiss OTC pharmaceutical industry and includes cough and cold, analgesics, skin products, vitamins and minerals, digestives and others. Market ...
This market research report gives a detailed analysis of the Irish pharmaceutical industry and includes prescription and OTC pharmaceuticals. Market assessement is based on domestic shipments. The information ...
While a ban on smoking in public places came into effect in October 2008, it did not result in an expansion in the availability of NRT smoking cessation aids in India. Despite growing awareness of the ...
This market research report gives a detailed analysis of the Mexican OTC pharmaceutical industry and includes cough & cold preparations, vitamins & minerals, medicated skin products, mycotic products, ...
Sales of OTC obesity treatments declined by 2% in 2009. The switch of Alli, the first FDA approved weight loss drug, is proving to be a disappointment for GlaxoSmithKline, despite the state of the US population ...
2009 proved to be a very challenging year for the slimming products segment , as weight loss supplements continued to freefall. Dietary supplements barely recovered in 2006 following the ephedra controversy, ...
Slimming products began to see sales decline in 2009. Meal replacement slimming drove the decline in sales recording a 2% drop in retail value terms. This drop of 2% was rather substantial as meal replacement ...
In 2009, slimming products registered negative value growth as a result of declining sales of meal replacement products, the dominant product range. This product recorded negative growth over the review ...
Various products and diet programmes to reduce body weight presented a considerable challenge to the sales of slimming products in 2009. Weight loss supplements were partly challenged by fibre drink brands ...
In line with EU regulations, products in OTC obesity were not available in Greece in 2008. However, in October 2008, the European Medicines Agency (EMEA) authorised the switching of active ingredient Orlistat ...
In 2009, studies indicated that out of a total population of 33 million, 6.7 million Algerians smoked. In 2008, it was also estimated that 15,000 Algerians die every year from smoking-related diseases. ...
Slimming products continued to be very small in 2009 despite the increasing visibility of these products in the country. The rather high prices of such products dissuade potential customers from buying ...
» Download Public Reports
About 300 reports
... Hormones (rivera et al., 2001).iodine deficiency disorders had been widely recognized as one of the important public health problems especially in developing countries throughout the world. According ...
» Read our Company Profiles
10 CompaniesReportlinker.com © Copyright 2013. All rights reserved.